Investor relations
Building the national engine.
Australia's specialist platform for AI integration, compliance and optimisation in healthcare. Patient outcomes and business performance, together. Pre-seed and seed stage.
The opportunity
Abe is developing reusable professional-information, learning-discovery and governance services for Australian healthcare. Its public course finder is working in Beta. Selected updates and existing organisational MCP/API access have their own source and permission requirements. The complete paid subscription and embedded customer journey remains unfinished; this page is not evidence of customers, revenue or clinical outcomes.
Fundraising scenarios — proposals requiring founder confirmation
- Option A — A$2.0M focused seed. GP / primary-care beachhead. 18-month runway to ~A$1.5–2M ARR and Series A readiness.
- Option B — A$3.5–5M broad seed. Whole-of-health go-to-market. 18–24 months to multi-domain traction and Series A.
- Pre-build option. A leaner A$750k–A$1.5M pre-seed to prove the engine and first logos on the proven stack, then raise the larger seed on traction at a better valuation.
- Possible non-dilutive funding. Eligibility and current availability require independent review; no award, application or funding commitment is claimed.
Trajectory proposal (illustrative — broad scenario)
| Year | Paying orgs | PHN / enterprise deals | Recognised revenue | ARR (year-exit) | Gross margin | Team |
|---|---|---|---|---|---|---|
| 1 | 120–160 | 1–2 | ~A$400–600k | ~A$550k | ~75% | ~12 |
| 2 | 500–700 | 4–8 | ~A$2.0–3.5M | ~A$3M | ~80% | ~20–28 |
| 3 | 1,400–2,200 | 10–18 | ~A$6–12M | ~A$9M | ~82% | ~35–50 |
All fundraising amounts and forecasts on this page are earlier illustrative proposals, not an approved offer, valuation, observed revenue or verified funding requirement. Confirm current figures, assumptions and documents with the founder before relying on them.
The moat
The product direction combines clinician-informed workflows, selected Australian source material and shared services for individuals, organisations and software teams. Source rights, currentness, customer adoption and each distribution channel need their own evidence. No unique competitive position, complete regulatory coverage or third-party compliance certification is asserted.
Team and build sequence
See /about for the founder and the journey end-to-end. Current services include a working Beta professional-development finder, selected official updates and Beta governance workflows. Existing organisational MCP/API access is separate from the unfinished individual subscription and shared-panel journey. Additional roles are a roadmap, not a published count of working agents; clinical decision support remains inactive.
Comparable transactions
- Request independently sourced, current market and transaction evidence before making an investment comparison.
Register interest
Investor Q&A
- What stage is Abe AI at?
- Beta services and integration infrastructure are implemented at different stages. The public finder is working; the complete paid subscription and embedded customer journey is unfinished. See Services for current access and boundaries. Proposed validation targets are not customer or revenue counts.
- Which legal entity operates Abe AI?
- Operator, registration and ownership details require founder confirmation. A transfer from a personal ABN to a company is not established by this page. Related products are potential distribution channels, not evidence of an accepted integration or paid customer.
- What is the moat against AMIDA Health AI, GetAIReady, and Big-Four consulting?
- Clinician-informed professional information and governance services, with a shared-service distribution model. Source coverage, vendor assessments and each channel require their own evidence; this is not a verified comparison of every competitor or a claim that all roadmap agents are working.
- What is the regulatory risk?
- Abe's active scope is non-clinical professional information and governance work, with human review. Regulatory classification depends on the actual intended purpose and functionality; this page does not establish an exemption. Patient-specific clinical decision support is inactive and requires separate regulatory and clinical acceptance.
- Why now?
- Healthcare organisations need to assess the technology, privacy and professional obligations that apply to their work. Abe provides supported services and is building the shared subscriber journey. Neither changing regulation nor a roadmap establishes market leadership, measured efficiency or guaranteed demand.
- Who is on the cap table today?
- Request the current ownership and capital-structure documents from the founder. This page does not establish a cap table, shareholder identity or completed company transfer.
For NDA-gated material, founder direct conversations, or to register a fund's interest, use the form above. Request acknowledgement and the expected response timeframe.